|
WDR61 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.88591414391249E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.97106783619938E-12 |
| Normal-vs-Stage2 |
5.80050000031918E-07 |
| Normal-vs-Stage3 |
3.427900E-04 |
| Normal-vs-Stage4 |
1.10619999826866E-08 |
| Stage1-vs-Stage2 |
5.454600E-01 |
| Stage1-vs-Stage3 |
4.454800E-01 |
| Stage1-vs-Stage4 |
1.882000E-01 |
| Stage2-vs-Stage3 |
2.822000E-01 |
| Stage2-vs-Stage4 |
6.602200E-01 |
| Stage3-vs-Stage4 |
1.172170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.50497408874162E-13 |
| Normal-vs-AfricanAmerican |
5.12640000005504E-07 |
| Normal-vs-Asian |
1.152610E-01 |
| Caucasian-vs-AfricanAmerican |
1.104210E-01 |
| Caucasian-vs-Asian |
7.471200E-01 |
| AfricanAmerican-vs-Asian |
3.846400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.65134572682746E-12 |
| Normal-vs-Female |
4.68649999996185E-06 |
| Male-vs-Female |
3.221700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.83489999999421E-05 |
| Normal-vs-Extreme_Weight |
2.13939976845268E-12 |
| Normal-vs-Obese |
2.40660003036908E-09 |
| Normal-vs-Extreme_Obese |
2.000600E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.950300E-02 |
| Normal_Weight-vs-Obese |
2.946000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.800000E-01 |
| Extreme_Weight-vs-Obese |
4.572600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.505800E-01 |
| Obese-vs-Extreme_Obese |
3.753600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.40890000002825E-06 |
| Normal-vs-Age(41-60Yrs) |
3.26070281886359E-11 |
| Normal-vs-Age(61-80Yrs) |
3.07420755518706E-12 |
| Normal-vs-Age(81-100Yrs) |
7.817700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.457970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.418370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.294200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.541800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.750800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.357800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.22835116814713E-14 |
| Normal-VS-Type2 PRCC |
4.12830000000586E-05 |
| Normal-VS-KIRP CIMP |
9.55124868085022E-12 |
| Normal-VS-Unclassified PRCC |
7.87230003407302E-09 |
| Type1 PRCC-VS-Type2 PRCC |
1.696350E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.401560E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.399000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.0893999999978E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
4.060200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.755530E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.55240273361323E-11 |
| Normal-vs-N1 |
1.601680E-03 |
| Normal-vs-N2 |
1.75980000000076E-05 |
| N0-vs-N1 |
3.969800E-01 |
| N0-vs-N2 |
5.659000E-01 |
| N1-vs-N2 |
4.415600E-01 |
|
|
